AEPH
Home > Conferences > Vol. 21. CESS2026 >
Single-Cell Transcriptomic Analysis of the Pediatric Gut in Crohn's Disease Reveals Compositional Remodeling toward an Inflammatory Cellular Landscape
DOI: https://doi.org/10.62381/ACS.CESS2026.04
Author(s)
Bingyao Chen
Affiliation(s)
Xi'an Jiaotong-Liverpool University, Suzhou, China
Abstract
Crohn's disease is a chronic inflammatory disorder of the gut. It often begins in childhood, and its cellular basis in young patients is still not fully understood. Bulk gene expression studies report average changes in tissue, but they cannot show which cell types drive disease. In this work we reanalyze a public single-cell RNA sequencing atlas of the pediatric human gut and compare children with Crohn's disease to healthy controls. After quality control we studied 17,965 cells from 15 donors, grouped into 31 cell types that span the epithelial, stromal, vascular, and immune compartments. We used a standard and open pipeline that includes quality control, normalization, batch integration with Harmony, graph based clustering, and marker based validation of cell identity. We then measured how the cell type composition differs between disease and control tissue. Crohn's disease tissue showed a clear shift toward an inflammatory landscape. Inflammatory monocytes, IgG plasma cells, fibroblasts, and blood vessel cells all increased in disease, while mature B cells and absorptive enterocytes decreased. The expansion of IgG plasma cells, monocytes, and stromal cells matches a known pathogenic module that is linked to poor drug response in adult Crohn's disease. The results give a clear, cell level picture of pediatric Crohn's disease and provide a reproducible base for biomarker work and for future spatial and predictive studies.
Keywords
RNA Sequencing; Crohn's Disease; Inflammatory Bowel Disease; Pediatric; Cell Type Composition; Gut Mucosa; Transcriptomics.
References
[1] GBD 2017 Inflammatory Bowel Disease Collaborators, "The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017," Lancet Gastroenterol. Hepatol., vol. 5, no. 1, pp. 17-30, 2020. [2] D. B. Graham and R. J. Xavier, "Pathway paradigms revealed from the genetics of inflammatory bowel disease," Nature, vol. 578, no. 7796, pp. 527-539, 2020. [3] J. C. Martin et al., "Single-cell analysis of Crohn's disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy," Cell, vol. 178, no. 6, pp. 1493-1508, 2019. [4] C. S. Smillie et al., "Intra- and inter-cellular rewiring of the human colon during ulcerative colitis," Cell, vol. 178, no. 3, pp. 714-730, 2019. [5] R. Elmentaite et al., "Cells of the human intestinal tract mapped across space and time," Nature, vol. 597, no. 7875, pp. 250-255, 2021. [6] K. Parikh et al., "Colonic epithelial cell diversity in health and inflammatory bowel disease," Nature, vol. 567, no. 7746, pp. 49-55, 2019. [7] CZ CELLxGENE Discover, single-cell data platform, Chan Zuckerberg Initiative. [Online]. Available: https://cellxgene.cziscience.com [8] F. A. Wolf, P. Angerer, and F. J. Theis, "SCANPY: large-scale single-cell gene expression data analysis," Genome Biol., vol. 19, art. 15, 2018. [9] I. Korsunsky et al., "Fast, sensitive and accurate integration of single-cell data with Harmony," Nat. Methods, vol. 16, pp. 1289-1296, 2019. [10] V. A. Traag, L. Waltman, and N. J. van Eck, "From Louvain to Leiden: guaranteeing well-connected communities," Sci. Rep., vol. 9, art. 5233, 2019. [11] L. McInnes, J. Healy, and J. Melville, "UMAP: uniform manifold approximation and projection for dimension reduction," arXiv:1802.03426, 2018. [12] T. Stuart et al., "Comprehensive integration of single-cell data," Cell, vol. 177, no. 7, pp. 1888-1902, 2019. [13] D. Kioroglou et al., "Single-cell analysis reveals significant transcriptomic alterations in preclinical Crohn's disease," Front. Immunol., vol. 16, art. 1539830, 2025. [14] I. S. Stafford et al., "A systematic review of artificial intelligence and machine learning applications to inflammatory bowel disease," Inflamm. Bowel Dis., vol. 28, no. 10, pp. 1573-1583, 2022. [15] Y. Miyamoto et al., "Spatial transcriptomics in autoimmune rheumatic disease: potential clinical applications and perspectives," Inflammation and Regeneration, vol. 45, art. 6, 2025. [16] M. H. D. Nazari, M. Ghorbaninejad, S. Shahrokh, and A. Meyfour, "Biomarker discovery for non-invasive diagnosis of inflammatory bowel disease using blood transcriptomics," Front. Immunol., vol. 16, art. 1570374, 2025. [17] F. Zhang et al., "Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry," Nat. Immunol., vol. 20, no. 7, pp. 928-942, 2019.
Copyright @ 2020-2035 Academic Education Publishing House All Rights Reserved